Drug Enforcement D-704-2013

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Status

Ongoing

Classification

Class II

Report Date

July 17, 2013

Termination Date

Product Information

Product description
Betamethasone Sodium Phosphate 12 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Product quantity
1
Reason for recall
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recall initiation reason
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Distribution pattern
Nationwide and PR

Location & Firm

Recalling firm
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Address
6700 Conroy Windermere Rd, Suite 140

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-704-2013
Event ID
65360
Recall initiation date
May 29, 2013
Center classification date
July 11, 2013
Code info
A5719 Exp 6/7/13
More code info